Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
biotech
boston blog main
2
×
boston top stories
2
×
cancer
cancer drugs
life sciences
national blog main
new york blog main
new york top stories
takeda pharmaceutical
abbvie
agios pharmaceuticals
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biontech
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
david e. shaw
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
drug discovery
dyne therapeutics
eli lilly
What
company’s
2
×
pipeline
acquisitions
biggest
bio
build
buy
ceo
course
daniel
debut
development
discover
drug
dyne’s
experimental
gilead
growing
handiwork
helped
internal
ipo
landscape
medicines
microbiome
moves
openly
o’day
roundup
scan
schrödinger
schrödinger’s
sciences
scores
seagen
sets
software
spoken
spot
support
Language
unset
Current search:
company’s
×
photo
×
" boston blog main "
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline